Tafamidis

ATTR Cardiomyopathy Drug Approved

The US FDA approved tafamidis meglumine (Vyndaqel) and tafamidis (Vyndamax) for the treatment of wild-type or hereditary transthyretin amyloid (ATTR)…

6 years ago

This website uses cookies.